Literature DB >> 8215727

The sepsis syndrome in a Dutch university hospital. Clinical observations.

H Kieft1, A I Hoepelman, W Zhou, M Rozenberg-Arska, A Struyvenberg, J Verhoef.   

Abstract

BACKGROUND: Most studies of the cause of sepsis syndrome focus on patients hospitalized in intensive care units. In this study, we analyzed the incidence, cause, and outcome of the sepsis syndrome in all hospitalized patients.
METHODS: Clinical and microbiologic data were obtained for 382 patients (5.6% of all patients admitted) from whom blood was drawn for culture.
RESULTS: The incidence of the sepsis syndrome was 13.6 per 1000 patients admitted (1.06 per 1000 hospital days), while the incidence of septic shock was 4.6 per 1000. The respiratory tract was the predominant infection site. Of all patients with sepsis syndrome, 38% (n = 35) had positive blood cultures. More than half of these cultures (13 [57%]) were caused by gram-positive microorganisms (excluding patients receiving selective decontamination of the digestive tract and those with intravascular device-related bacteremias). The mortality for patients with sepsis syndrome without shock was 28% (17/61), while for patients with septic shock, it was 55% (17/31). Patients with cardiovascular diseases had a significantly (P < .005) greater risk of dying during a sepsis syndrome episode than patients with other predisposing factors. Multivariate analysis of factors influencing outcome identified the development of shock and an immunocompromised state as being significantly associated with outcome in patients with sepsis syndrome.
CONCLUSIONS: Patients fulfilling the criteria for the sepsis syndrome are at great risk of developing septic shock or multiple-organ failure and subsequently dying. In our hospital, the majority of bacteremic episodes were associated with gram-positive microorganisms.

Entities:  

Mesh:

Year:  1993        PMID: 8215727

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  17 in total

1.  Evidence-based Medicine in Infectious Diseases and Microbiology: Still a Long Way to Go.

Authors:  Jan Verhoef
Journal:  Curr Infect Dis Rep       Date:  2003-04       Impact factor: 3.725

Review 2.  [The cost of sepsis].

Authors:  O Moerer; H Burchardi
Journal:  Anaesthesist       Date:  2006-06       Impact factor: 1.041

3.  Sepsis, SIRS and infection.

Authors:  W J Sibbald; G Doig; K J Inman
Journal:  Intensive Care Med       Date:  1995-04       Impact factor: 17.440

4.  Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation.

Authors:  Seiji Madoiwa; Shin Nunomiya; Tomoko Ono; Yuichi Shintani; Tsukasa Ohmori; Jun Mimuro; Yoichi Sakata
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

5.  Staphylococcus aureus induces release of bradykinin in human plasma.

Authors:  E Mattsson; H Herwald; H Cramer; K Persson; U Sjöbring; L Björck
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

6.  The role of nitric oxide in experimental murine sepsis due to pyrogenic exotoxin A-producing Streptococcus pyogenes.

Authors:  S Sriskandan; D Moyes; L K Buttery; J Wilkinson; T J Evans; J Polak; J Cohen
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

7.  The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure.

Authors:  S J De Kimpe; M Kengatharan; C Thiemermann; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  The diagnostic value of serum leptin monitoring and its correlation with tumor necrosis factor-alpha in critically ill patients: a prospective observational study.

Authors:  Ayman Abd Al-Maksoud Yousef; Yasser Mohamed Amr; Ghada Abdulmomen Suliman
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097

9.  Pneumonia-induced sepsis in mice: temporal study of inflammatory and cardiovascular parameters.

Authors:  Regina Sordi; Octávio Menezes-de-Lima; Ana M Della-Justina; Edir Rezende; Jamil Assreuy
Journal:  Int J Exp Pathol       Date:  2013-02-27       Impact factor: 1.925

10.  Clinical comparison of isolator and thiol broth with ESP aerobic and anaerobic bottles for recovery of pathogens from blood.

Authors:  J A Kellogg; D A Bankert; J P Manzella; K S Parsey; S L Scott; S H Cavanaugh
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.